-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Vidarabine monohydrate
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/24356-66-9.gif)
| Category | Herpes simplex Virus (HSV) |
| CAS | 24356-66-9 |
| Description | Vidarabine is a nucleoside antibiotic effective against herpes simplex virus types 1 (HSV-1), 2 (HSV-2) and varicella zoster viruses (VZV). |
Product Information
| Synonyms | Spongoadenosine monohydrate; Vira-A monohydrate; (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol hydrate |
| IUPAC Name | (2R,3S,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;hydrate |
| Molecular Weight | 285.26 |
| Molecular Formula | C10H13N5O4·H2O |
| Canonical SMILES | C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N.O |
| InChI | InChI=1S/C10H13N5O4.H2O/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H2/t4-,6-,7+,10-;/m1./s1 |
| InChIKey | ZTHWFVSEMLMLKT-CAMOTBBTSA-N |
| Melting Point | 257.0-257.5°C (0.4 H2O) |
| Purity | 99.96% |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | White to off-white (Solid) |
| Storage | Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month |
| Complexity | 335 |
| Exact Mass | 285.10731860 |
| PSA | 148.77000 |
| Target | HSV; Antibiotic |
